Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.75
-0.15 (-2.54%)
At close: Mar 9, 2026, 4:00 PM EDT
5.90
+0.15 (2.61%)
After-hours: Mar 9, 2026, 5:44 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $308.13 million as of March 9, 2026. Its market cap has increased by 61.01% in one year.
Market Cap
308.13M
Enterprise Value
180.84M
1-Year Change
61.01%
Ranking
Category
Stock Price
$5.75
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $308.13M, an increase of 77.94%. That is a compound annual growth rate of 9.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 328.78M |
| X4 Pharmaceuticals | 328.76M |
| Relmada Therapeutics | 326.33M |
| Rezolute | 323.04M |
| Avalo Therapeutics | 320.46M |
| Greenwich LifeSciences | 319.90M |
| Nautilus Biotechnology | 312.61M |
| XOMA Royalty | 308.86M |